26 May 2013
Keywords: synosia, names, hans-rudolf, olpe, vp, neuropharmacology, swiss
Article | 08 September 2008
Swiss Synosia Therapeutics has named Hans-Rudolf Olpe vice president of neuropharmacology. Dr Olpe previously served as head of the stroke
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
24 May 2013
© 2013 thepharmaletter.com